Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance -

NCT02106455 · clinicaltrials.gov ↗
COMPLETED
Status
315
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda